JP2009519002A5 - - Google Patents

Download PDF

Info

Publication number
JP2009519002A5
JP2009519002A5 JP2006528286A JP2006528286A JP2009519002A5 JP 2009519002 A5 JP2009519002 A5 JP 2009519002A5 JP 2006528286 A JP2006528286 A JP 2006528286A JP 2006528286 A JP2006528286 A JP 2006528286A JP 2009519002 A5 JP2009519002 A5 JP 2009519002A5
Authority
JP
Japan
Prior art keywords
antibody
polypeptide
cancer
group
tables
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006528286A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009519002A (ja
Filing date
Publication date
Priority claimed from US10/669,920 external-priority patent/US20060194265A1/en
Application filed filed Critical
Publication of JP2009519002A publication Critical patent/JP2009519002A/ja
Publication of JP2009519002A5 publication Critical patent/JP2009519002A5/ja
Pending legal-status Critical Current

Links

JP2006528286A 2003-09-23 2004-09-23 癌における新規の治療標的 Pending JP2009519002A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/669,920 US20060194265A1 (en) 2001-10-23 2003-09-23 Novel therapeutic targets in cancer
PCT/US2004/031617 WO2005031001A2 (en) 2003-09-23 2004-09-23 Novel therapeutic targets in cancer

Publications (2)

Publication Number Publication Date
JP2009519002A JP2009519002A (ja) 2009-05-14
JP2009519002A5 true JP2009519002A5 (enExample) 2009-06-25

Family

ID=34393436

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006528286A Pending JP2009519002A (ja) 2003-09-23 2004-09-23 癌における新規の治療標的

Country Status (6)

Country Link
US (2) US20060194265A1 (enExample)
EP (1) EP1685157A2 (enExample)
JP (1) JP2009519002A (enExample)
AU (1) AU2004276821A1 (enExample)
CA (1) CA2539709A1 (enExample)
WO (1) WO2005031001A2 (enExample)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7892730B2 (en) * 2000-12-22 2011-02-22 Sagres Discovery, Inc. Compositions and methods for cancer
EP2058408A3 (en) 2003-02-14 2009-09-09 Sagres Discovery, Inc. Therapeutic GPCR targets in cancer
US12110555B2 (en) 2004-12-08 2024-10-08 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease
US11268149B2 (en) 2004-12-08 2022-03-08 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease
WO2006092062A1 (en) * 2005-03-04 2006-09-08 The Hospital For Sick Children Methods for cancer prognosis
EP1865981A2 (en) * 2005-04-07 2007-12-19 Chiron Corporation Cacna1e in cancer diagnosis, detection and treatment
WO2006110594A2 (en) * 2005-04-07 2006-10-19 Novartis Vaccines And Diagnostics Inc. Sema4d in cancer diagnosis, detection and treatment
JP5219029B2 (ja) 2005-05-02 2013-06-26 東レ株式会社 食道ガン及び食道ガン転移診断のための組成物及び方法
JP2007116905A (ja) * 2005-10-24 2007-05-17 Natl Inst Of Radiological Sciences 放射線治療における副作用発症予測用ポリヌクレオチドおよび放射線治療における副作用発症予測方法
US7655778B2 (en) * 2006-02-28 2010-02-02 Curonix Co., Ltd. SISP-1, a novel p53 target gene and use thereof
CN101496387B (zh) 2006-03-06 2012-09-05 思科技术公司 用于移动无线网络中的接入认证的系统和方法
JP2010511382A (ja) * 2006-12-01 2010-04-15 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 癌関連タンパク質キナーゼ
US8652472B2 (en) * 2006-12-05 2014-02-18 Oncomed Pharmaceuticals, Inc. Compositions and methods for diagnosing and treating cancer
KR101568049B1 (ko) 2006-12-18 2015-11-11 제넨테크, 인크. 항-ｎｏｔｃｈ3 길항제 항체 및 ｎｏｔｃｈ3-관련 질환의 예방 및 치료에 있어서 그의 용도
US8570373B2 (en) 2007-06-08 2013-10-29 Cisco Technology, Inc. Tracking an object utilizing location information associated with a wireless device
US8355041B2 (en) 2008-02-14 2013-01-15 Cisco Technology, Inc. Telepresence system for 360 degree video conferencing
US8797377B2 (en) 2008-02-14 2014-08-05 Cisco Technology, Inc. Method and system for videoconference configuration
US8319819B2 (en) 2008-03-26 2012-11-27 Cisco Technology, Inc. Virtual round-table videoconference
US8390667B2 (en) 2008-04-15 2013-03-05 Cisco Technology, Inc. Pop-up PIP for people not in picture
EP2313435A4 (en) * 2008-07-01 2012-08-08 Aveo Pharmaceuticals Inc FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) BINDING PROTEINS
US8477175B2 (en) 2009-03-09 2013-07-02 Cisco Technology, Inc. System and method for providing three dimensional imaging in a network environment
US8659637B2 (en) 2009-03-09 2014-02-25 Cisco Technology, Inc. System and method for providing three dimensional video conferencing in a network environment
US8659639B2 (en) 2009-05-29 2014-02-25 Cisco Technology, Inc. System and method for extending communications between participants in a conferencing environment
KR101071219B1 (ko) * 2010-03-12 2011-10-10 가톨릭대학교 산학협력단 간암진단용 ＴＧＦβＲΙΙΙ 유전자의 단일 뉴클레오티드 다형성 마커
US9225916B2 (en) 2010-03-18 2015-12-29 Cisco Technology, Inc. System and method for enhancing video images in a conferencing environment
USD626103S1 (en) 2010-03-21 2010-10-26 Cisco Technology, Inc. Video unit with integrated features
USD626102S1 (en) 2010-03-21 2010-10-26 Cisco Tech Inc Video unit with integrated features
USD628175S1 (en) 2010-03-21 2010-11-30 Cisco Technology, Inc. Mounted video unit
US9313452B2 (en) 2010-05-17 2016-04-12 Cisco Technology, Inc. System and method for providing retracting optics in a video conferencing environment
US8896655B2 (en) 2010-08-31 2014-11-25 Cisco Technology, Inc. System and method for providing depth adaptive video conferencing
US9632088B2 (en) * 2010-09-07 2017-04-25 Memorial Sloan-Kettering Cancer Center Methods and compositions for gamma-secretase assay
US8599934B2 (en) 2010-09-08 2013-12-03 Cisco Technology, Inc. System and method for skip coding during video conferencing in a network environment
US9338394B2 (en) 2010-11-15 2016-05-10 Cisco Technology, Inc. System and method for providing enhanced audio in a video environment
US8902244B2 (en) 2010-11-15 2014-12-02 Cisco Technology, Inc. System and method for providing enhanced graphics in a video environment
US8730297B2 (en) 2010-11-15 2014-05-20 Cisco Technology, Inc. System and method for providing camera functions in a video environment
US8723914B2 (en) 2010-11-19 2014-05-13 Cisco Technology, Inc. System and method for providing enhanced video processing in a network environment
US9111138B2 (en) 2010-11-30 2015-08-18 Cisco Technology, Inc. System and method for gesture interface control
USD682293S1 (en) 2010-12-16 2013-05-14 Cisco Technology, Inc. Display screen with graphical user interface
USD682294S1 (en) 2010-12-16 2013-05-14 Cisco Technology, Inc. Display screen with graphical user interface
USD678308S1 (en) 2010-12-16 2013-03-19 Cisco Technology, Inc. Display screen with graphical user interface
USD678307S1 (en) 2010-12-16 2013-03-19 Cisco Technology, Inc. Display screen with graphical user interface
USD678320S1 (en) 2010-12-16 2013-03-19 Cisco Technology, Inc. Display screen with graphical user interface
USD682854S1 (en) 2010-12-16 2013-05-21 Cisco Technology, Inc. Display screen for graphical user interface
USD678894S1 (en) 2010-12-16 2013-03-26 Cisco Technology, Inc. Display screen with graphical user interface
USD682864S1 (en) 2010-12-16 2013-05-21 Cisco Technology, Inc. Display screen with graphical user interface
EP2681333B1 (en) 2011-03-01 2017-11-15 Yale University EVALUATING RESPONSE TO THERAPY OF GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NENs)
FR2992427A1 (fr) * 2012-06-20 2013-12-27 Assist Publ Hopitaux De Paris Methode de pronostic d'un lymphome et kit pour sa mise en oeuvre
CA2893977C (en) 2012-12-21 2024-02-13 Seattle Genetics, Inc. Anti-ntb-a antibodies and related compositions and methods
US20160039877A1 (en) 2013-03-15 2016-02-11 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions and methods of using islet neogenesis peptides and analogs thereof
US9458464B2 (en) 2014-06-23 2016-10-04 The Johns Hopkins University Treatment of neuropathic pain
US10975122B2 (en) * 2014-11-25 2021-04-13 Technion Research & Development Foundation Limited Epitope as a target for therapy of inflammatory autoimmune diseases and graft rejection
US10980897B2 (en) 2015-09-17 2021-04-20 Research Institute At Nationwide Children's Hospital Methods and materials for GALGT2 gene therapy
EP3282019A1 (en) 2016-08-09 2018-02-14 Medizinische Universität Wien Genotyping and treatment of cancer, in particular chronic lymphocytic leukemia
WO2019012336A2 (en) 2017-03-17 2019-01-17 Newcastle University ADENO-ASSOCIATED VIRAL VECTOR DELIVERY OF A MICRO-DYSTROPHIN FRAGMENT FOR TREATING MUSCLE DYSTROPHY
MD3774897T2 (ro) 2018-04-30 2024-02-29 Cedars Sinai Medical Center Metode și sisteme de selectare și tratare a pacienților cu boli inflamatorii
FI3807413T3 (fi) 2018-06-18 2025-08-13 Res Inst Nationwide Childrens Hospital Lihasspesifisen mikrodystrofiinin annostelu adeno-assosioituneella virusvektorilla lihasdystrofian hoitamiseksi
CA3123872A1 (en) 2018-12-28 2020-07-02 Catalyst Biosciences, Inc. Modified urokinase-type plasminogen activator polypeptides and methods of use
US12012441B2 (en) 2020-10-26 2024-06-18 Neptune Biosciences Llc Engineered human IL-21 cytokines and methods for using the same
WO2025014844A1 (en) * 2023-07-07 2025-01-16 The Regents Of The University Of California Compositions and methods to treat liver, kidney and cell proliferative diseases and disorders

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852506B1 (en) * 1996-04-10 2005-02-08 Human Genome Sciences, Inc. Extracellular/epidermal growth factor-like protein
US7321023B2 (en) * 1997-11-07 2008-01-22 Incyte Corporation SP16 protein
US6828097B1 (en) * 2000-05-16 2004-12-07 The Childrens Mercy Hospital Single copy genomic hybridization probes and method of generating same
GB0020953D0 (en) * 2000-08-24 2000-10-11 Smithkline Beecham Biolog Vaccine
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
US7892730B2 (en) * 2000-12-22 2011-02-22 Sagres Discovery, Inc. Compositions and methods for cancer
US7820447B2 (en) * 2000-12-22 2010-10-26 Sagres Discovery Inc. Compositions and methods for cancer
US20030232334A1 (en) * 2000-12-22 2003-12-18 Morris David W. Novel compositions and methods for cancer
US20040072264A1 (en) * 2000-12-22 2004-04-15 Morris David W. Novel compositions and methods for cancer
US20030216558A1 (en) * 2000-12-22 2003-11-20 Morris David W. Novel compositions and methods for cancer
US20040072154A1 (en) * 2000-12-22 2004-04-15 Morris David W. Novel compositions and methods for cancer
US7083913B2 (en) * 2001-01-18 2006-08-01 The Regents Of The University Of California High through-put cloning of protooncogenes
WO2003008583A2 (en) * 2001-03-02 2003-01-30 Sagres Discovery Novel compositions and methods for cancer
US7171311B2 (en) * 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
CA2451168A1 (en) * 2001-10-30 2003-05-08 Ortho-Clinical Diagnostics, Inc. Methods for assessing and treating leukemia
JP3662897B2 (ja) * 2002-05-31 2005-06-22 株式会社水道技術開発機構 仕切り用弁装置
EP2151507B1 (en) * 2002-12-20 2013-02-13 Celera Corporation Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
EP1938104A2 (en) * 2005-10-17 2008-07-02 Institute for Systems Biology Tissue-and serum-derived glycoproteins and methods of their use

Similar Documents

Publication Publication Date Title
JP2009519002A5 (enExample)
CA2882759C (en) Detection of the ntrk1-mprip gene fusion for cancer diagnosis
US20170114415A1 (en) Activating ntrk1 gene fusions predictive of kinase inhibitor therapy
JP2019216725A (ja) Ｆｇｆｒ融合体
JP2009039107A5 (enExample)
CA2488404A1 (en) Genes and polypeptides relating to human colon cancers
CA2807104C (en) Bard1 isoforms in lung and colorectal cancer and use thereof
Lee et al. Combination of immunohistochemistry, FISH and RT-PCR shows high incidence of Xp11 translocation RCC: comparison of three different diagnostic methods
JP2008535856A5 (enExample)
JP2004533825A5 (enExample)
JP2007508020A5 (enExample)
DK2148932T3 (en) SOX11 expression in malignant lymphomas
JP2008535855A5 (enExample)
EP4157879A1 (en) Anti-human lag-3 antibodies and their use in immunohistochemistry (ihc)
JP2009523004A5 (enExample)
KR20120134547A (ko) 항-ａｔｉｃ 자가면역항체를 포함하는 간암 진단 마커 및 이의 항원을 포함하는 간암 진단용 조성물
CN107709362B (zh) Igf-1r抗体及其用于癌症诊断的用途
JP2008535854A5 (enExample)
JP4967137B2 (ja) 癌治療用組成物
KR102549771B1 (ko) 대장암 전이 억제제 스크리닝 방법
CN108456249B (zh) 变异型α-辅肌动蛋白-4的抗体
CN112143805A (zh) Rit1在肝细胞癌的诊断和治疗中的应用
KR102528973B1 (ko) 면역항암요법에 대한 바이오마커 및 이의 용도
CN111394463B (zh) 一种与甲状腺癌相关的分子及其应用
KR20190058082A (ko) 유방암의 진단 및 치료를 위한 바이오 마커